Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck-Medco Analysis Finds 11% Of Rx Market Will Go Generic In 3-5 Years

Executive Summary

Merck-Medco projects that products representing 11% of current drug spending will have generic alternatives over the next three to five years.

You may also be interested in...



Caremark PBM Services Could Reduce Senior Rx Costs By 26.5%, Firm Says

Caremark's PBM services could reduce an uninsured senior citizen's average annual pharmaceutical spending by 26.5%, the company told a June 5 securities analysts meeting at its new Mount Prospect, Ill. mail order pharmacy.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
UsernamePublicRestriction

Register

PS037996

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel